CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $29.21 million. The enterprise value is $20.38 million.

Market Cap	29.21M
Enterprise Value	20.38M

Important Dates

The last earnings date was Wednesday, March 26, 2025, before market open.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

CLGN has 11.45 million shares outstanding. The number of shares has increased by 0.57% in one year.

Current Share Class	11.45M
Shares Outstanding	11.45M
Shares Change (YoY)	+0.57%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	32.27%
Owned by Institutions (%)	15.48%
Float	7.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	56.72
Forward PS	1.97
PB Ratio	2.17
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	39.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.23.

Current Ratio	4.44
Quick Ratio	4.21
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.46% and return on invested capital (ROIC) is -44.88%.

Return on Equity (ROE)	-79.46%
Return on Assets (ROA)	-40.81%
Return on Invested Capital (ROIC)	-44.88%
Return on Capital Employed (ROCE)	-109.60%
Revenue Per Employee	$6,867
Profits Per Employee	-$221,453
Employee Count	75
Asset Turnover	0.02
Inventory Turnover	2.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.24% in the last 52 weeks. The beta is 0.70, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-51.24%
50-Day Moving Average	3.43
200-Day Moving Average	4.24
Relative Strength Index (RSI)	25.09
Average Volume (20 Days)	12,053

Short Selling Information

Short Interest	1,858
Short Previous Month	4,831
Short % of Shares Out	0.02%
Short % of Float	n/a
Short Ratio (days to cover)	0.49

Income Statement

In the last 12 months, CLGN had revenue of $515,000 and -$16.61 million in losses. Loss per share was -$1.45.

Revenue	515,000
Gross Profit	-1.11M
Operating Income	-17.25M
Pretax Income	-7.50M
Net Income	-16.61M
EBITDA	-16.21M
EBIT	-17.25M
Loss Per Share	-$1.45

Full Income Statement

Balance Sheet

The company has $11.91 million in cash and $3.08 million in debt, giving a net cash position of $8.83 million or $0.77 per share.

Cash & Cash Equivalents	11.91M
Total Debt	3.08M
Net Cash	8.83M
Net Cash Per Share	$0.77
Equity (Book Value)	13.47M
Book Value Per Share	1.18
Working Capital	10.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.09 million and capital expenditures -$483,000, giving a free cash flow of -$14.58 million.

Operating Cash Flow	-14.09M
Capital Expenditures	-483,000
Free Cash Flow	-14.58M
FCF Per Share	-$1.27

Full Cash Flow Statement

Margins

Gross Margin	-215.53%
Operating Margin	-3,349.71%
Pretax Margin	-3,225.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.57%
Shareholder Yield	n/a
Earnings Yield	-56.86%
FCF Yield	-49.90%

Analyst Forecast

The average price target for CLGN is $12.50, which is 390.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.50
Price Target Difference	390.20%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.6666666:1

Scores

CLGN has an Altman Z-Score of -4.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.32
Piotroski F-Score	1